louisiana semaglutide gastric stasis lawsuit Woman sues drug makers of Ozempic and Mounjaro over severe gastrointestinal issues glp-1 diarrhea class action in

Retatrutide taps into three

TRULICITY is not for use in people with type 1 diabetes and is not recommended for use in people with severe stomach or intestinal problems

Its active ingredient, semaglutide, has a 94% similar structure to the glucagon-like peptide-1 hormone, a naturally occurring hormone that your body produces after food intake to regulate appetite and blood sugar levels

It is not known if Wegovy injection is safe and effective: to reduce the risk of major cardiovascular events (death, heart attack, or stroke) in people under 18 years to help children under 12 years of age lose weight and keep the weight off This site is intended for US patients only